The WNT/ β-catenin system in chronic kidney disease-mineral bone disorder syndrome

ConclusionsThe WNT/ β-catenin signaling pathway is a potential therapeutic target for CKD-MBD. Small molecular compounds that target the components or regulatory molecules of the pathway may provide a promising approach to treat CKD-MBD. However, more research is needed to identify safe and effective compounds and to determine the optimal dosages and treatment regimens.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research